Enzalutamide Adds Five Months Survival in Late-Stage Prostate Cancer
Enzalutamide adds five months survival in late-stage prostate cancer
Filed under: Colorado Drug Treatment Centers
It provides both more benefit and less harm – you get the quantification of more life, but also see quality of life improvements," says study co-author, Thomas Flaig, MD, medical director of the University of Colorado Cancer Center's Clinical …
Read more on Medical Xpress
Gateway Foundation Testifies for Substance Abuse Treatment Parity at Chicago …
Filed under: Colorado Drug Treatment Centers
About Gateway Foundation Alcohol & Drug Treatment Gateway Foundation Alcohol & Drug Treatment is Illinois' largest provider of substance abuse treatment, providing services for adults and adolescents at treatment centers throughout the state. Gateway …
Read more on Sacramento Bee
Heterogeneous ER+ breast cancer models allow more accurate drug testing
Filed under: Colorado Drug Treatment Centers
Cell cultures are homogeneous. Human tumors are not. A University of Colorado Cancer Center study recently published in the journal Breast Cancer Research and Treatment reports the development of human-derived estrogen-positive (ER+) breast cancer …
Read more on Science Codex
More Colorado Drug Treatment Centers Resources
Enzalutamide Adds 5 Months Survival In Late-stage Prostate Cancer
( University of Colorado Denver ) Results of a Phase III clinical trial of the drug enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer. … Read News
Enzalutamide Adds Five Months Survival In Late-stage Prostate Cancer
Results of a Phase III clinical trial of the drug enzalutamide show the drug extends life by an average five months in the most advanced stages of prostate cancer. … Read News